Pediatria Polska

Abstract

3/2020 vol. 95
Case report

Association of Budd-Chiari syndrome, essential thrombocytosis, and celiac disease

  1. Department of Gastroenterology, Hepatology, Nutritional Disorders and Pediatrics, The Children’s Memorial Health Institute, Warsaw, Poland
  2. Department of Paediatrics, Haematology, and Oncology, Medical University of Warsaw, Warsaw, Poland
  3. Deptartment of Pathology, The Children’s Memorial Health Institute, Warsaw, Poland
  4. Deptartment of Radiology, The Children’s Memorial Health Institute, Warsaw, Poland
  5. Deptartment of Radiology, Medical University of Warsaw, Warsaw, Poland
Pediatr Pol 2020; 95 (3): 191–195
Online publish date: 2020/10/30
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Herein we report the case of a girl with association of Budd-Chiari syndrome (BCS), essential thrombocythaemia (ET), and celiac disease (CD). To our knowledge, this is one out of eight cases in the literature of BCS complicated with CD, and the only one complicated with ET. This case is particularly significant because anagrelide therapy was started at an unusually early age. A four-year-old girl with ET treated with anagrelide was admitted to our hospital with suspicion of BCS. Ultrasound colour Doppler and computed tomography imaging revealed enlargement of the caudate lobe, splenomegaly, accessory hepatic veins, umbilical vein recanalisation, and ascites. The diagnosis of the CD was confirmed by serology (EmA IgA 1 : 800, tTG IgA > 130 U/ml). Two years later Duhring’s disease was confirmed histologically with recovery after diet modification. Four years later she is still being treated with anagrelide, anticoagulant drugs and is on a well-controlled gluten-free diet.
Share
without publication fees
without publication fees